Show simple item record

What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?

dc.contributor.authorFalay, Mesude
dc.contributor.authorSenes, Mehmet
dc.contributor.authorYücel, Dogan
dc.contributor.authorTurhan, Turan
dc.contributor.authorDagdaş, Simten
dc.contributor.authorPekin, Melike
dc.contributor.authorNazaroglu, Namik K
dc.contributor.authorÖzet, Gülsüm
dc.date.accessioned2021-02-01T14:45:03Z
dc.date.available2021-02-01T14:45:03Z
dc.date.issued2018-07-01
dc.identifier.other29484705
dc.identifier.urihttp://hdl.handle.net/20.500.12591/542
dc.publisherTıp Fakültesien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleWhat should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?en_US
dc.contributor.departmentDahili Tıp Bilimlerien_US


Files in this item

Thumbnail
Name:
JCLA-32-e22415.pdf
Size:
354.6Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record